Syndax Pharmaceuticals (SNDX) Net Margin (2015 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Net Margin of 65.43% for Q1 2026, up 35655.0% year-over-year from N/an in Q1 2025, and down 32.16% quarter-over-quarter from 49.51% in Q4 2025.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Net Margin (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Net Margin history runs 10 years deep, the most recent figure standing at 65.43% for Q1 2026.
- In Q1 2026, Net Margin rose 35655.0% year-over-year to 65.43%; the TTM figure through Mar 2026 stood at 97.82% (up 67516.0% YoY), while the FY2025 annual figure was 178.26%, up 223821.0% from the prior year.
- Net Margin for Q1 2026 stood at 65.43%, down from 49.51% in the prior quarter.
- The five-year high for Net Margin was 49.51% in Q4 2025, with the low at 2145.54% in Q2 2024.
- The 3-year median for Net Margin is 310.77% (2025), against an average of 614.1%.
- The sharpest annual moves came in 2025 and 2026: Net Margin soared 194599 bps in 2025, then jumped 35655 bps in 2026.
- Syndax Pharmaceuticals' Net Margin stood at 1225.7% in 2024, then soared by 96 bps to 49.51% in 2025, then tumbled by 32 bps to 65.43% in 2026.
- Business Quant data shows SNDX's Net Margin at 65.43% in Q1 2026, 49.51% in Q4 2025, and 131.8% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | 12.09% |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -3.12% |
| 10 | Syndax Pharmaceuticals | 1.83 Bn | 1.28 Bn | 60.67 Mn | -49.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49.80% |
| Mar 31, 2026 | -53.41% |
| Dec 31, 2025 | -84.71% |
| Sep 30, 2025 | -113.70% |
| Jun 30, 2025 | -167.05% |
| Mar 31, 2025 | -416.10% |
| Dec 31, 2024 | -1,160.59% |
| Sep 30, 2024 | -673.26% |
| Jun 30, 2024 | -2,124.66% |
| Dec 31, 2021 | 75.72% |
| Sep 30, 2021 | -166.45% |
| Jun 30, 2021 | -6,058.05% |
| Mar 31, 2021 | -7,327.97% |
| Dec 31, 2020 | -5,365.53% |
| Sep 30, 2020 | -5,359.10% |
| Jun 30, 2020 | -4,532.72% |
| Mar 31, 2020 | -4,089.97% |
| Dec 31, 2019 | -3,679.74% |
| Sep 30, 2019 | -3,365.17% |
| Jun 30, 2019 | -4,043.27% |